Related Experiment Video

Updated: Jul 10, 2026

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

Selective regulation of mutant K-ras mRNA expression by photo-cross-linking antisense oligonucleotide

Maiko Higuchi1, Asako Yamayoshi, Akio Kobori

  • 1Department of Biomolecular Engineering, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto606-8585, Japan.

Nucleic Acids Symposium Series (2004)
|November 22, 2007
PubMed

Insights

Researchers developed novel photo-reactive antisense oligonucleotides to target cancer-causing gene mutations. The 2'-O-psoralen-conjugated adenosine molecules show high efficiency in photo-cross-linking to specific messenger RNA sequences.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Genetics

Background:

  • Point mutations in genes are a significant cause of various cancers.
  • Selective regulation of gene expression is crucial for developing novel anticancer drugs.

Purpose of the Study:

  • To design and synthesize novel photo-reactive antisense oligonucleotides capable of sequence-specific photo-cross-linking to target mRNA with point mutations.
  • To evaluate the efficiency and specificity of these novel molecules for potential anticancer drug development.

Main Methods:

  • Synthesis of photo-reactive antisense oligonucleotides (2"-Ps-oligos) conjugated with 2 -O-psoralen via different linkers: ethoxymethylene (2 -Ps-eom), propoxymethylene (2 -Ps-pom), and butoxymethylene (2 -Ps-bom).
  • Evaluation of photo-cross-linking efficiency and sequence specificity of the synthesized 2 -Ps-oligos against complementary RNA.

Main Results:

  • The synthesized 2 -Ps-oligos demonstrated sequence-specific photo-cross-linking capabilities to target mRNA.
  • Among the tested derivatives, 2 -Ps-eom exhibited the highest photo-cross-linking efficiency.

Conclusions:

  • Novel photo-reactive antisense oligonucleotides have been successfully designed and synthesized.
  • The 2 -Ps-eom derivative shows promising potential for targeted gene regulation in cancer therapy due to its high photo-cross-linking efficiency.

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.